Cancer Research Targets  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sodir, N. M.
Right arrow Articles by Laird, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sodir, N. M.
Right arrow Articles by Laird, P. W.
[Cancer Research 66, 8430-8438, September 1, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Smad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice

Nicole M. Sodir1, Xuan Chen3, Ryan Park5, Andrea E. Nickel1, Peter S. Conti5, Rex Moats4, James R. Bading5, Darryl Shibata2 and Peter W. Laird1

Departments of 1 Surgery and Biochemistry and Molecular Biology and 2 Pathology, Norris Comprehensive Cancer Center; 3 Department of Pathology and Laboratory Medicine and 4 Saban Research Institute, Children's Hospital Los Angeles; 5 PET Imaging Science Center, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California

Requests for reprints: Peter W. Laird, University of Southern California/Norris Comprehensive Cancer Center, Room 6418, 1441 Eastlake Avenue, Los Angeles, CA 90089-9176. Phone: 323-865-0650; Fax: 323-865-0158; E-mail: plaird{at}usc.edu.

Colorectal cancer, one of the most common human malignancies in the Western world, is often subdivided based on tumor location in either the distal or proximal colon. Several mouse models have been developed to study human colorectal cancer, but few display this clear distinction between the two colonic locations. By crossing ApcMin/+ and Smad3 mutant mice, we showed that combined activation of the Wnt pathway and attenuation of the transforming growth factor-ß (TGF-ß) pathway causes high multiplicity and rapid onset of invasive tumorigenesis almost exclusively in the distal colon, closely mimicking the familial adenomatous polyposis (FAP) disease and consisting with distinct colorectal cancer etiologies based on tumor location. Transcriptional profiling revealed higher expression of several TGF-ß activators in the normal distal mucosa than in proximal mucosa, suggesting a stronger reliance on TGF-ß-mediated growth control in the distal than in the proximal colon. ApcMin/+Smad3–/– mice provide an alternative model to ApcMin/+ mice to study FAP and distal sporadic colorectal cancer. This model will be useful in dissecting mechanistic and etiologic differences between proximal and distal colonic cancer, whereas the confinement of tumorigenesis to the distal colon offers unique advantages in monitoring tumor progression by in vivo imaging. (Cancer Res 2006; 66(17): 8430-8)




This article has been cited by other articles:


Home page
Cancer Res.Home page
Q. Zeng, S. Phukan, Y. Xu, M. Sadim, D. S. Rosman, M. Pennison, J. Liao, G.-Y. Yang, C.-C. Huang, L. Valle, et al.
Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development
Cancer Res., January 15, 2009; 69(2): 678 - 686.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Zhao, G. Aguilar, S. Palencia, E. Newton, and A. Abo
rNAPc2 Inhibits Colorectal Cancer in Mice through Tissue Factor
Clin. Cancer Res., January 1, 2009; 15(1): 208 - 216.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Yang, N. V. Popova, W. C. Yang, I. Lozonschi, S. Tadesse, S. Kent, L. Bancroft, I. Matise, R. T. Cormier, S. J. Scherer, et al.
Interaction of Muc2 and Apc on Wnt Signaling and in Intestinal Tumorigenesis: Potential Role of Chronic Inflammation
Cancer Res., September 15, 2008; 68(18): 7313 - 7322.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. Valle, T. Serena-Acedo, S. Liyanarachchi, H. Hampel, I. Comeras, Z. Li, Q. Zeng, H.-T. Zhang, M. J. Pennison, M. Sadim, et al.
Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer
Science, September 5, 2008; 321(5894): 1361 - 1365.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Xu and B. Pasche
TGF-{beta} signaling alterations and susceptibility to colorectal cancer
Hum. Mol. Genet., April 15, 2007; 16(R1): R14 - R20.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. G. Deane, H. C. Manning, A. C. Foutch, M. K. Washington, B. A. Aronow, D. J. Bornhop, and R. J. Coffey
Targeted Imaging of Colonic Tumors in Smad3-/- Mice Discriminates Cancer and Inflammation
Mol. Cancer Res., April 1, 2007; 5(4): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Amos-Landgraf, L. N. Kwong, C. M. Kendziorski, M. Reichelderfer, J. Torrealba, J. Weichert, J. D. Haag, K.-S. Chen, J. L. Waller, M. N. Gould, et al.
A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer
PNAS, March 6, 2007; 104(10): 4036 - 4041.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.